HER2 positivity predicts a benefit from paclitaxel treatment after adjuvant chemotherapy
- PMID: 18364725
- DOI: 10.1038/ncponc1092
HER2 positivity predicts a benefit from paclitaxel treatment after adjuvant chemotherapy
Comment on
-
HER2 and response to paclitaxel in node-positive breast cancer.N Engl J Med. 2007 Oct 11;357(15):1496-506. doi: 10.1056/NEJMoa071167. N Engl J Med. 2007. PMID: 17928597 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous